Key result
Mononuclear cells from patients with clinically active sarcoidosis spontaneously produced CDI-MLx in amounts comparable to maximally stimulated normal cells.
Observational
In active sarcoidosis, a subpopulation of natural killer-like cells spontaneously produces a monocyte leukotaxis inhibitor, which may play a role in granuloma formation.
Answers are grounded in this paper and cite their sources.
May not alter sarcoidosis management; leaves open whether CDI-MLx inhibition could modulate granuloma formation in vivo.
Sarcoidosis is an immunopathogenic disorder of uncertain cause. Because the regulation of monocyte mobilization and function may be critical to granuloma formation in this disease, we evaluated production of the cell-directed inhibitor of monocyte leukotaxis (CDI-MLx) by peripheral blood and bronchoalveolar lavage mononuclear cells from these patients. Cells obtained from either source during clinically active disease spontaneously produced this leukotactic regulator in vitro in amounts comparable to those achieved with maximal mitogenic stimulation of normal cells. Plasma leukotactic inhibitory activity and spontaneous inhibitor production were significantly associated. Plasma inhibitory activity and CDI-MLx production were normal in patients whose disease was inactive. Spontaneous production continued for at least 7 days in vitro and could not be attributed to alterations in the absolute numbers of specific mononuclear cell populations. Partitioning of peripheral blood mononuclear cells by a combination of E-rosetting and immunoadherence techniques indicated, however, that CDI-MLx was produced by a subpopulation of natural killer-like cells that formed E-rosettes and bore the OKMI and Leu 7 membrane antigens.
No takes yet. Share an insight, caveat, or question.
Campbell et al. (1986) conducted an observational in Sarcoidosis. Clinically active sarcoidosis vs. Inactive disease and normal cells was evaluated on Production of cell-directed inhibitor of monocyte leukotaxis (CDI-MLx). Mononuclear cells from patients with clinically active sarcoidosis spontaneously produced CDI-MLx in amounts comparable to maximally stimulated normal cells.
Synapse has enriched 10 related papers. Consider them for comparative context: